Sanofi Lantus brand insulin pens are positioned for a photo shoot in Brooklyn, New York, April 5, 2019.
Alex Flynn Bloomberg | Getty Images
Americans now have access regardless of their insurance status. sanofiInsulin, the most widely prescribed insulin in the US, is available for $35 through prescription drug savings companies Good Rcompanies announced Thursday.
Patients with a valid prescription can specifically access a $35 coupon for Sanofi’s Lantus on the GoodRx site and redeem it at more than 70,000 retail locations in the United States. CVS, walgreens and walmart.
The effort is aimed at making Lantus’ $35 price point more widely available to Americans, similar to its competitors even after Sanofi. Eli Lilly and novo nordisk —Earlier this year, it announced significant price cuts and out-of-pocket caps on insulin.
The three companies, which control more than 90% of the global insulin market, moved to lower prices after years of political pressure and public anger over the high prices Americans pay for diabetes treatment. Approximately 8 times We consume more insulin than other developed countries, making this country a country with diabetes. most expensive chronic disease.
Sanofi announced in March that it would lower the list price of Lantus and limit out-of-pocket costs for policyholders to $35 per month. However, this change will not take effect until January.
The French company also has an existing patient assistance program that caps insulin prices at the same price for uninsured diabetics. But some patients struggle to access the $35 price point, even with the program in place.
This is due to low patient awareness of copay cards and patient savings programs that can help with out-of-pocket costs. Health experts and patient advocates have expressed concerns: those programsManufacturer-run services often make people jump through hoops just to save money.
According to one study, pharmaceutical companies spend more than $5 billion each year marketing patient support programs, but only 3% of patients actually take advantage of them. 2021 survey From Freesia Life Sciences.
President Joe Biden’s Inflation Control Act also capped monthly insulin costs for Medicare recipients at $35, but provided no protection for diabetics with private insurance.
According to , approximately 37 million people in the United States, or 11.3% of the country’s population, have diabetes. Centers for Disease Control and Prevention. Approximately 8.4 million diabetics are insulin dependent. american diabetes association Said.
Don’t miss the next article on CNBC PRO.
